We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clarifies Steps for Sponsors to Submit Alternative ICH Postmarket Reports
FDA Clarifies Steps for Sponsors to Submit Alternative ICH Postmarket Reports
Drug sponsors hoping to submit an alternative postmarket report, known as the periodic benefit-risk evaluation report (PBRER), at a different frequency than required should plan to file a waiver request, the FDA said.